Research output per year
Research output per year
Personal profile
Research interests
My interest is in clinical cancer research. I am interested in new drug development, particularly as it relates to prostate, kidney, colon and pancreatic cancer. I am also interested in clinical trials, and involved in fellowship education, along with innovative trial design.
Clinical interests
Diagnosis of tumors, renal cell carcinoma, RCC, pancreatic cancer, pancreas, cholangiocarcinoma, prostate cancer, colon cancer, bladder cancer, rectal carcinoma, immunotherapy, chemotherapy, GI cancer, GU cancer
Fingerprint
Dive into the research topics where Joel Picus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma
Msaouel, P., Sweis, R. F., Bupathi, M., Heath, E., Goodman, O. B., Hoimes, C. J., Milowsky, M. I., Davis, N., Kalebasty, A. R., Picus, J., Shaffer, D., Mao, S., Adra, N., Yorio, J., Gandhi, S., Grivas, P., Siefker-Radtke, A., Yang, R., Latven, L. & Olson, P. & 4 others, , Aug 1 2024, In: European Urology Oncology. 7, 4, p. 933-943 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma
Petrylak, D. P., Eigl, B. J., George, S., Heath, E. I., Hotte, S. J., Chism, D. D., Nabell, L. M., Picus, J., Cheng, S. Y., Appleman, L. J., Sonpavde, G. P., Morgans, A. K., Pourhosseini, P., Wu, R., Standley, L., Croitoru, R. & Yu, E. Y., Jan 10 2024, In: Clinical Cancer Research. 30, 1, p. 63-73 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
PRESTO Study Investigators, Apr 1 2024, In: Journal of Clinical Oncology. 42, 10, p. 1114-1123 10 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
von der Maase, H., Hansen, S. W., Roberts, J. T., Dogliotti, L., Oliver, T., Moore, M. J., Bodrogi, I., Albers, P., Knuth, A., Lippert, C. M., Kerbrat, P., Sanchez Rovira, P., Wersall, P., Cleall, S. P., Roychowdhury, D. F., Tomlin, I., Visseren-Grul, C. M., Conte, P. F., Holm, N. V. & Nielsen, K. & 84 others, , Aug 10 2023, In: Journal of Clinical Oncology. 41, 23, p. 3881-3890 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., Gilson, M. M., Wang, C., Selby, M., Taube, J. M., Anders, R., Chen, L., Korman, A. J., Pardoll, D. M., Lowy, I. & Topalian, S. L., Feb 1 2023, In: Journal of Clinical Oncology. 41, 4, p. 715-723 9 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations